This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2018 Jun 10;36(17):1647-1648.

doi: 10.1200/JCO.2018.78.2102. Epub 2018 Apr 30.

Breaking the Glass Ceiling of Overall Survival in Non-Small-Cell Lung Cancer

Niels Reinmuth¹, Martin Reck¹

Affiliations

PMID: 29708807
DOI: 10.1200/JCO.2018.78.2102

Editorial

Breaking the Glass Ceiling of Overall Survival in Non-Small-Cell Lung Cancer

Niels Reinmuth et al. J Clin Oncol. 2018.

. 2018 Jun 10;36(17):1647-1648.

doi: 10.1200/JCO.2018.78.2102. Epub 2018 Apr 30.

Authors

Niels Reinmuth¹, Martin Reck¹

Affiliation

¹ Niels Reinmuth, Asklepios Clinics Munich-Gauting, Gauting, Germany; and Martin Reck, German Center for Lung Research, Grosshansdorf, Germany.

PMID: 29708807
DOI: 10.1200/JCO.2018.78.2102

No abstract available

PubMed Disclaimer

Comment on

Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: Results From the CA209-003 Study.
Gettinger S, Horn L, Jackman D, Spigel D, Antonia S, Hellmann M, Powderly J, Heist R, Sequist LV, Smith DC, Leming P, Geese WJ, Yoon D, Li A, Brahmer J. Gettinger S, et al. J Clin Oncol. 2018 Jun 10;36(17):1675-1684. doi: 10.1200/JCO.2017.77.0412. Epub 2018 Mar 23. J Clin Oncol. 2018. PMID: 29570421 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information